Alopecia Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Alopecia Clinical Trials Market Report Overview
The Alopecia clinical trial market research report provides an overview of the Alopecia Clinical trials scenario. This report provides top-line data relating to the clinical trials on Alopecia and an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report also offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. It also provides prominent drugs for in-progress trials (based on the number of ongoing trials).
Key Regions | · North America
· Asia-Pacific · Europe · Middle East & Africa · South & Central America |
Key Countries | · United States
· India · Iran · China · Germany · Egypt · Japan · South Korea · Thailand · Australia |
Key Sponsor Types | · Institution
· Company · Government |
Leading Sponsors | · Pfizer Inc
· Sun Pharmaceutical Industries Ltd · Kintor Pharmaceutical Ltd · Johnson & Johnson · AbbVie Inc |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Alopecia Clinical Trials Market Segmentation by Regions and Countries
The key regions in the Alopecia clinical trials market are North America, Asia-Pacific, Europe, the Middle East & Africa, and South & Central America, among others. Asia-Pacific dominates the market with more than 35% of the clinical trials conducted as of July 2023.
In the country-wise analysis, the US has the highest number of alopecia clinical trials, as of July 2023. Germany has the highest average patient enrollment of alopecia clinical trials, as of July 2023.
G7 and E7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, the United States has the highest proportion of Alopecia to Dermatology clinical trials as of July 2023. On the other hand, among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, India has the highest proportion of Alopecia in dermatology clinical trials as of July 2023.
Alopecia Clinical Trials Analysis by Regions, 2023 (%)
For more regional insights into the Alopecia clinical trials market, download a free report sample
Alopecia Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the Alopecia clinical trials market are institutions, companies, and the government. Out of them, the company sponsor type dominates the market.
Alopecia Clinical Trials Market Analysis by Sponsor Types, 2023 (%)
For more sponsor type insights into the Alopecia clinical trials market, download a free report sample
Alopecia Clinical Trials Market - Competitive Landscape
The leading sponsors in the Alopecia clinical trials market are Pfizer Inc, Sun Pharmaceutical Industries Ltd, Kintor Pharmaceutical Ltd, Johnson & Johnson, and AbbVie Inc among others. Pfizer Inc led the Alopecia clinical trials market in July 2023.
Alopecia Clinical Trials Market Analysis by Sponsors, 2023 (%)
To know more about the leading sponsors in the Alopecia clinical trials market, download a free report sample
Segments Covered in the Report
Alopecia Clinical Trials Regional Outlook (2023)
- North America
- Asia-Pacific
- Europe
- Middle East & Africa
- South & Central America
Alopecia Clinical Trials Country Outlook (2023)
- United States
- India
- Iran
- China
- Germany
- Egypt
- Japan
- South Korea
- Thailand
- Australia
Alopecia Clinical Trials Sponsor Type Outlook (2023)
- Institution
- Company
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status.
- The report reviews the top companies involved and enlists all trials (trial title, phase, and Status) pertaining to the company.
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for unaccomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- Assists in formulating key business strategies with regard to investment.
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost.
- Provides top-level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities.
- Supports understanding of trial count and enrollment trends by country in the global therapeutics market.
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials.
- Facilitates clinical trial assessment of the indication on a global, regional, and country level.
Sun Pharmaceutical Industries Ltd
Kintor Pharmaceutical Ltd
AbbVie Inc
Johnson & Johnson
Aclaris Therapeutics Inc
Cosmo Pharmaceuticals NV
Dr. Reddy's Laboratories Ltd
Jupiter Wellness Inc
Almirall SA
Table of Contents
Table
Figures
Frequently asked questions
-
Which was the leading region in the Alopecia clinical trials market?
Asia Pacific was the leading region in the Alopecia clinical trials market as of July 2023.
-
Which was the leading country in the Alopecia clinical trials market?
The US was the leading country in the Alopecia clinical trials market as of July 2023.
-
Which was the leading sponsor type in the Alopecia clinical trials market?
The company was the leading sponsor type in the Alopecia clinical trials market as of July 2023.
-
Who are the leading sponsors in the Alopecia clinical trials market?
The leading sponsors in the Alopecia clinical trials market are Pfizer Inc, Sun Pharmaceutical Industries Ltd, Kintor Pharmaceutical Ltd, Johnson & Johnson, and AbbVie Inc among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.